N-terminal proBNP levels can predict cardiac failure after cardiac surgery

Circulation Journal

Volumn 71, Issue 1, 2007, Pages 79-83

  Cerrahoglu, Mustafa ^a   Iskesen, Ihsan ^a   Tekin, Cetin ^a   Onur, Ece ^a   Yildirim, Funda ^a   Sirin, B Hayrettin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Cardiac failure; Coronary artery bypass; NT proBNP

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; NORADRENALIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEVICE; FEMALE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART SURGERY; HEMODYNAMICS; HUMAN; INOTROPISM; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PULSE RATE; RISK FACTOR; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

AGED; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846009139     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.79     Document Type: Article

References (25)

1. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol (Orf) 1997; 47: 287-296.
2. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
3. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, Yano K. Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 2005; 69: 83-88.
4. Mockel M, Muller R, Vollert JO, Muller C, Carl A, Peetz D, et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 2005; 51: 1624-1631.
5. Tateyama H, Hino J, Minamino N, Kangawa K, Minamino T, Sakai K, et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem Biophys Res Commun 1992; 185: 760-767.
6. Hong SN, Yoon NS, Ahn Y, Lim SY, Kim YS, Yun KH, et al. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes. Circ J 2005; 69: 1472-1476.
7. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005; 11(Suppl): S15-S20.
8. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402-1412.
9. Fonseca C, Sarmento PM, Minez A, Goncalves E, Covas R, Dias AR, et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Rev Port Cardiol 2004; 23: 979-991.
10. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004; 6: 289-293.
11. Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Clin Biochem, 2006; 39: 640-645.
12. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89: 745-751.
13. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-Type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-2792.
14. Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Ishizaka Y, Yokota N, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 1995; 43: 237-242.
15. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Am Heart J 2006; 151: 999-1005.
16. Talwar S, Siebenhofer A, Williams B, Ng L. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart 2000; 83: 278-282.
17. Atinou A, Burch M, Elliott M, Carter N. Brain natriuretic peptide and fluid volume homeostasis: Studies during cardiopulmonary bypass surgery. Clin Auton Res 1993; 3: 275-280.
18. Katayama T, Yano K, Nakashima H, Takagi C, Honda Y, Suzuki S, et al. Clinical significance of acute-phase endotherm-1 in acute myocardial infarction patients treated with direct coronary angioplasty. Circ J 2005; 69: 654-658.
19. Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, et al. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function. J Heart Lung Transplant 2006; 25: 596-602.
20. Al-Meslmani BM, Fahoum SK, Shamia MG. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure. Saudi Med J 2005; 26: 1695-1698.
21. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90: 297-303.
22. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. J Am Coll Cardiol 2006; 47: 345-353.
23. Morimoto K, Mori T, Ishiguro S, Matsuda N, Hara Y, Kuroda H. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 1998; 28: 23-29.
24. Forfia PR, Watkins SP, Rame JE, Steward KJ, Shapiro EP. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005; 45: 1667-1671.
25. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43: 1873-1879.